Proton Therapy in Reducing Toxicity in Anal Cancer
Running, not enrolling · Phase 2
Conditions studied: Anus Neoplasms
In brief
The purpose of this research study is to determine whether the amount of radiation given to the normal areas around the anal cancer can be reduced by using Proton Therapy while reducing the side effects that are seen with standard therapy.
Key facts
- Study ID
- NCT03018418
- Run by
- Jordan Kharofa
- People needed
- 14
- Starts
- 2017-01-04
- Expected to finish
- 2025-07-01
- Last updated by the study team
- 2024-09-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Karnofsky Performance Status >70%
- Histologically documented squamous or basaloid carcinoma of the anal canal
- Stage T2-4 disease with any N category
You may not qualify if…
- Patients with a life expectancy of < 3 months.
Where it is running
- UC Health — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.